CVE-2026-18953Improper limitation of a pathname to a restricted directory in aws-transform-mcp-server
Updated under an hour ago ()
Does this affect you?
It affects aws-transform-mcp-server and 1 other product. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
Improper limitation of a pathname to a restricted directory in the get_resource tool in Amazon awslabs.aws-transform-mcp-server 0.1.0 through 0.1.4 might allow a context-dependent actor to write arbitrary files outside the intended working directory via the savePath parameter. To remediate this issue, users should upgrade to version 0.1.5 or later.
- CVSS
- 8.6 HIGH (v3.1, CNA)CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:C/C:H/I:H/A:H
- Weakness (CWE)
- CWE-22
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- AMZN
- NVD analysis
- Analyzed
- Record last updated
- Aug 6, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
AWS aws-transform-mcp-server aws:transform_mcp_server (from the name) | from 0.1.0 through 0.1.4 | CNA record |
amazon aws_transform_mcp_server amazon:aws_transform_mcp_server | from 0.1.0 before 0.1.5 | NVD |
References
- https://pypi.org/project/awslabs.aws-transform-mcp-server/0.1.5/release-notes, patch, product
- https://aws.amazon.com/security/security-bulletins/2026-075-aws/vendor-advisory
- https://github.com/awslabs/mcp/security/advisories/GHSA-66mr-jr63-2jgwrelease-notes, vendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.